Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WEC vs GSK✓SelectedUSD · GSKWEC vs GSK performance historyLatest closeAs of-0.12%11/16
Stock and ETF performance explorer

WEC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+54.6%
GSK return
+46.9%
Excess return
+7.7%
Maximum drawdown
-26.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-0.1%0.0%-0.1%
7D+1.1%-1.3%+2.4%+1.4%
30D+8.9%+2.7%+6.2%+8.3%
3M+7.1%+2.7%+4.4%+6.4%
6M+9.4%+3.3%+6.1%+8.5%
YTD+15.2%+6.5%+8.7%+13.1%
1Y+9.5%+10.7%-1.2%+6.6%
3Y+58.5%+64.4%-5.8%+38.1%
5Y+54.6%+46.7%+7.9%+32.8%
All+54.6%+46.9%+7.7%+32.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling